Updated Jul 16, 2026
Kenney Richard T is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Richard T. Kenney is the Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. He has been involved in the company through various SEC filings, indicating a role in its medical and clinical strategy.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 163.8K | — | |
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | M — Option exercise | 163.8K | — | |
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 69.6K | — | |
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | F — Tax withholding / forfeiture | 16.9K | — | |
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | M — Option exercise | 86.5K | — | |
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 9.4K | — | |
| 2025-07-11 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 8.0K | — | |
| 2024-12-05 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 1.3K | — |
Richard T. Kenney is the Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. He has been involved in the company through various SEC filings, indicating a role in its medical and clinical strategy.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kenney Richard T profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.